Evidence map›Paper›PMID 33168054›Full record

ArticleJournal of medical case reports2020

An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report.

Alice Serafini, Peter Konstantin Kurotschka, Mariabeatrice Bertolani, Silvia Riccomi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alice SerafiniAzienda USL di Modena, Via Bernardino Ramazzini 90, 41121, Modena MO, Emilia Romagna Region, Italy. alice.serafini@hotmail.it.ORCID http://orcid.org/0000-0002-7396-2839
Peter Konstantin KurotschkaDepartment of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Mariabeatrice BertolaniSection of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Silvia RiccomiAzienda USL di Modena, Via Bernardino Ramazzini 90, 41121, Modena MO, Emilia Romagna Region, Italy.
Azienda Unita' Sanitaria Locale Di Modena · ITUniversity of Cagliari · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19). The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in their crucial activity of case identification. CASE PRESENTATION: The patient is an Italian 32-year-old female nurse who had several close contacts with multiple patients with COVID-19 as part of her professional workload. On March 13, 2020, the patient developed an itchy, erythematous papular rash (sparing only her face, scalp, and abdomen), which lasted for 10 days. The rash was accompanied by a feeling of general fatigue that gradually worsened over the following days and has continued for 5 months (until the end of July 2020). During the first week of remote assessment carried out by her general practitioner, the patient gradually developed a dry cough, intermittent fever, and diarrhoea and then had a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Her skin manifestations disappeared completely 48 days after the onset of the disease, followed by the disappearance of the dry cough.

conclusionsIn light of recent studies, this case report suggests that skin manifestations, when taken into account with other situational factors (such as profession and patient history) should be taken into proper consideration by frontline physicians as possibly being caused by SARS-CoV-2. Early identification of COVID-19 is a key part of the strategy of case detection and case isolation. To enhance this activity, further research is needed to establish frequency, symptoms, signs, and pathogenesis of skin manifestations in patients with COVID-19.

Indexed as

AdultBetacoronavirusCoronavirus InfectionsCOVID-19ExanthemaFemaleHumansPandemicsPneumonia, ViralPruritusRisk FactorsSARS-CoV-2COVID-19General practitionersPrimary healthcareSigns and symptomsSkin manifestations

Identifiers

PMID33168054
PMCPMC7649709
OpenAlexW3106314652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.